Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgical Endoscopy
Published in: Surgical Endoscopy 1/2017

01-01-2017

Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy in super obese patients

Authors: Adam C. Celio, Qiang Wu, Kevin R. Kasten, Mark L. Manwaring, Walter J. Pories, Konstantinos Spaniolas

Published in: Surgical Endoscopy | Issue 1/2017

Login to get access

Abstract

Background

The disproportionate increase in the super obese (SO) is a hidden component of the current obesity pandemic. Data on the safety and efficacy of bariatric procedures in this specific patient population are limited. Our aim is to assess the comparative effectiveness of the two most common bariatric procedures in the SO.

Methods

Using the Bariatric Outcomes Longitudinal Database from 2007 to 2012, we compared SO patients (BMI ≥ 50) undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG). Stepwise logistic regression modeling was used to calculate a propensity score to adjust for patient demographics and comorbidities.

Results

We identified 50,987 SO patients who underwent RYGB (N = 42,119) or SG (N = 8868). There was no difference in adjusted overall 30-day complication rate comparing RYGB and SG patients (11.5 vs. 11.1 %, p = 0.250). RYGB patients had higher adjusted rates of 30-day mortality (0.3 vs. 0.2 %, p = 0.042), reoperation (4.0 vs. 2.4 %, p < 0.001), and readmission (6.9 vs. 5.5 %, p < 0.001) compared to SG patients. The percent of total weight loss (%TWL) was significantly higher for RYGB patients compared to SG at 3 months (14.1 vs. 13.1 %, p < 0.001), 6 months (25.2 vs. 22.4 %, p < 0.001), and 12 months (34.5 vs. 29.7 %, p < 0.001). RYGB patients had increased resolution of all measured comorbidities: diabetes mellitus (61.6 vs. 50.8 %, p < 0.001), hypertension (43.1 vs. 34.5 %, p < 0.001), gastroesophageal reflux disease (53.9 vs. 32.5 %, p < 0.001), hyperlipidemia (39.7 vs. 32.5 %, p < 0.001), and obstructive sleep apnea (42.8 vs. 40.6 %, p = 0.058) at 12 months compared to SG patients.

Conclusions

There are significant differences in comorbidity improvement and resolution as well as weight loss between RYGB and SG in the SO population. There was no difference in overall 30-day complications, but more RYGB patients required readmission and reoperation. However, RYGB was considerably more effective in controlling obesity-related comorbidities. Our results favor performance of RYGB in SO patients of appropriate risk.
Literature
1.
Sturm R (2003) Increases in clinically severe obesity in the United States, 1986–2000. Arch Intern Med 163:2146CrossRefPubMed
2.
Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 307:491CrossRefPubMed
3.
Prachand VN, Ward M, Alverdy JC (2009) Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI ≥ 50 kg/m2) compared with gastric bypass. J Gastrointest Surg 14:211–220CrossRef
4.
5.
Ikramuddin S, Korner J, Lee W-J, Connett JE, Inabnet WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang L-M, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP (2013) Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. JAMA 309:2240CrossRefPubMedPubMedCentral
6.
Kashyap SR, Bhatt DL, Wolski K, Watanabe RM, Abdul-Ghani M, Abood B, Pothier CE, Brethauer S, Nissen S, Gupta M, Kirwan JP, Schauer PR (2013) Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 36:2175–2182CrossRefPubMedPubMedCentral
7.
Oʼbrien PE, Macdonald L, Anderson M, Brennan L, Brown WA (2013) Long-term outcomes after bariatric surgery. Ann Surg 257:87–94CrossRefPubMed
8.
Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:246–256CrossRef
9.
Pories WJ, Swanson MS, Macdonald KG, Long SB, Morris PG, Brown BM, Barakat HA, Deramon RA, Israel G, Dolezal JM, Dohm L (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–352CrossRefPubMedPubMedCentral
10.
Telem DA, Talamini M, Shroyer AL, Yang J, Altieri M, Zhang Q, Gracia G, Pryor AD (2014) Long-term mortality rates (>8-year) improve as compared to the general and obese population following bariatric surgery. Surg Endosc 29:529–536CrossRefPubMed
11.
Andreyeva T, Sturm R, Ringel JS (2004) Moderate and severe obesity have large differences in health care costs. Obes Res 12:1936–1943CrossRefPubMed
12.
Zerrweck C, Sepúlveda EM, Maydón HG, Campos F, Spaventa AG, Pratti V, Fernández I (2013) Laparoscopic gastric bypass vs. sleeve gastrectomy in the super obese patient: early outcomes of an observational study. Obes Surg 24:712–717CrossRef
13.
Joshi GP, Ahmad S, Riad W, Eckert S, Chung F (2014) Selection of obese patients undergoing ambulatory surgery. Surv Anesthesiol 58:57CrossRef
14.
Serrano OK, Tannebaum JE, Cumella L, Choi J, Vemulapalli P, Melvin WS, Camacho DR (2015) Weight loss outcomes and complications from bariatric surgery in the super super obese. Surg Endosc. doi:10.​1007/​s00464-015-4509-y PubMed
15.
Abeles D, Kim JJ, Tarnoff ME, Shah S, Shikora SA (2009) Primary laparoscopic gastric bypass can be performed safely in patients with BMI ≥ 60. J Am Coll Surg 208:236–240CrossRefPubMed
16.
Gould JC, Garren MJ, Boll V, Starling JR (2006) Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients. Surgery 140:524–531CrossRefPubMed
17.
Zak Y, Petrusa E, Gee DW (2015) Laparoscopic Roux-en-Y gastric bypass patients have an increased lifetime risk of repeat operations when compared to laparoscopic sleeve gastrectomy patients. Surg Endosc 30:1833–1838CrossRefPubMed
18.
Young MT, Gebhart A, Phelan MJ, Nguyen NT (2015) Use and outcomes of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass: analysis of the American College of Surgeons NSQIP. J Am Coll Surg 220(5):880–885CrossRefPubMed
19.
Gagner M, Gumbs AA, Milone L, Yung E, Goldenberg L, Pomp A (2008) Laparoscopic sleeve gastrectomy for the super-super-obese (body mass index >60 kg/m2). Surg Today 38:399–403CrossRefPubMed
20.
Alexandrou A, Felekouras E, Giannopoulos A, Tsigris C, Diamantis T (2012) What is the actual fate of super-morbid-obese patients who undergo laparoscopic sleeve gastrectomy as the first step of a two-stage weight-reduction operative strategy? Obes Surg 22:1623–1628CrossRefPubMed
21.
Spaniolas K, Kasten KR, Brinkley J, Sippey ME, Mozer A, Chapman WH, Pories WJ (2015) The changing bariatric surgery landscape in the USA. Obes Surg 25:1544–1546CrossRefPubMed
22.
23.
Demaria EJ, Pate V, Warthen M, Winegar DA (2010) Baseline data from American society for metabolic and bariatric surgery-designated bariatric surgery centers of excellence using the bariatric outcomes longitudinal database. Surg Obes Relat Dis 6:347–355CrossRefPubMed
24.
Sczepaniak JP, Owens ML, Shukla H, Perlegos J, Garner W (2014) Comparability of weight loss reporting after gastric bypass and sleeve gastrectomy using BOLD data 2008–2011. Obes Surg 25:788–795CrossRef
25.
Thereaux J, Corigliano N, Poitou C, Oppert JM, Czernichow S, Bouillot JL (2015) Comparison of results after one year between sleeve gastrectomy and gastric bypass in patients with BMI > 50 kg/m2. Surg Obes Relat Dis 11(4):785–790CrossRefPubMed
26.
Khan S, Rock K, Baskara A, Qu W, Nazzal M, Ortiz J (2015) Trends in bariatric surgery from 2008 to 2012. Am J Surg 211:1041–1046CrossRefPubMed
27.
Li J, Lai D, Wu D (2015) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg 26:429–442CrossRef
28.
Peterli R, Borbely Y, Kern B, Gass M, Peters T, Thurnheer M, Schultles B, Laederach K, Bueter M, Schiesser M (2013) Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg 258(5):690–694CrossRefPubMedPubMedCentral
29.
Bays HE, Chapman RH, Grandy S (2007) The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 61:737–747CrossRefPubMedPubMedCentral
30.
Melton GB, Steele KE, Schweitzer MA, Lidor AO, Magnuson TH (2007) Suboptimal weight loss after gastric bypass surgery: correlation of demographics, comorbidities, and insurance status with outcomes. J Gastrointest Surg 12:250–255CrossRefPubMed
31.
Suter M, Calmes JM, Paroz A, Romy S, Giusti V (2009) Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients: similar body weight loss, correction of comorbidities, and improvement of quality of life. Arch Surg 144(4):312–318CrossRefPubMed
32.
Parikh MS, Shen R, Weiner M, Siegel N, Ren CJ (2005) Laparoscopic bariatric surgery in super-obese patients (BMI > 50) is safe and effective: a review of 332 patients. Obes Surg 15:858–863CrossRefPubMed
Metadata
Title
Comparative effectiveness of Roux-en-Y gastric bypass and sleeve gastrectomy in super obese patients
Authors
Adam C. Celio
Qiang Wu
Kevin R. Kasten
Mark L. Manwaring
Walter J. Pories
Konstantinos Spaniolas
Publication date
01-01-2017
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 1/2017
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-4974-y

Other articles of this Issue 1/2017

Surgical Endoscopy 1/2017 Go to the issue

OriginalPaper

Safely extending the indications of laparoscopic liver resection: When should we start laparoscopic major hepatectomy?

OriginalPaper

Surgical flow disturbances in dedicated minimally invasive surgery suites: an observational study to assess its supposed superiority over conventional suites

OriginalPaper

Single-incision endoscopic thyroidectomy by the axillary approach with gas inflation for the benign thyroid tumor: retrospective analysis for a single surgeon’s experience

Dynamic Manuscript

Single-port endoscopic mesocolic and mesorectal excision using an extraperitoneal approach

OriginalPaper

Consistency of patient-reported outcomes after cholecystectomy and their implications on current surgical practice: a prospective multicenter cohort study

OriginalPaper

Treatment outcomes and recurrence following standard cold forceps polypectomy for diminutive polyps